⌘K

Home/Filings/4/0001213900-23-002260

4//SEC Filing

Bandari Jathin 4

Accession 0001213900-23-002260

CIK 0001359931other

View on SEC.gov Company Profile

Filed

Jan 10, 7:00 PM ET

Accepted

Jan 11, 4:02 PM ET

Size

5.0 KB

Accession

0001213900-23-002260

Insider Transaction Report

Form 4

Period: 2023-01-10

Protara Therapeutics, Inc.TARA

Chief Medical Officer

Transactions

Tax Payment
Common Stock
2023-01-10$3.00/sh−1,876$5,628→ 18,442 total

Footnotes (1)

[F1]Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 10, 2022.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Protara Therapeutics, Inc.

CIK 0001359931

Entity typeother

Related Parties

1

filerCIK 0001903622

Filing Metadata

Form type: 4
Filed: Jan 10, 7:00 PM ET
Accepted: Jan 11, 4:02 PM ET
Size: 5.0 KB

View on SEC.gov